Skip to content

Brain Connectivity and Response to Tai Chi in Geriatric Depression

Brain Connectivity and Response to Tai Chi in Geriatric Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02460666
Enrollment
220
Registered
2015-06-02
Start date
2016-01-31
Completion date
2020-12-01
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

depressed, older adults, Major Depressive Disorder, Tai-Chi, geriatric

Brief summary

The purpose of this study is to evaluate the effects after up to 1 year of supervised weekly Tai-Chi-Chi versus Health Education and Wellness classes on reduction of depressive symptoms and improvement in resilience, health functioning, quality of life, cognition, sleep, fMRI neural correlates of working memory, and brain structure.

Detailed description

The proposed randomized trial aims to investigate neural mechanisms of brain connectivity when comparing response to TCC to health and wellness education classes using fMRI biomarkers of emotional regulation and cognition. Control group will include health wellness education programs (HEW) that will help to control for the non-specific social support factors. Primary outcomes include measures of depressive symptom severity. Secondary outcomes include cognition, resilience, health functioning, quality of life. Maintenance of response and relapse of major depression will be determined during 6 month (and 12 month follow-up if MRI eligible). Functional magnetic resonance imaging (fMRI) correlates of emotional processing and connectivity in related functional networks. Neural correlates of working memory, and brain structure will be examined in ½ of the sample. The researchers will investigate whether variations in emotional regulation will moderate or predict emotional and functional improvement linked to TCC. The investigators will recruit 220 older adults with depressive symptoms who have been on a stable form of treatment for at least 4 months, who will be randomly assigned to 12 weeks of: 1.Ta-Chi-Chih (TCC) class; or 2. Health/Wellness Education Program (HEW); all for 120 minutes per week. All subjects will receive comprehensive evaluations of mood, mental and physical health, and cognition at baseline, 12 weeks, and 6 months. Changes over time in measures of depressive symptoms, resilience, quality of life, and cognition will be assessed in random regression models. The investigators anticipate that greater clinical improvement in mood and cognition will in the TCC group compared to the HEW. The investigators also expect clinical improvement to correlate with the change in the activation in the right ventrolateral prefrontal cortex (VLPFC) and amygdala in an affect labeling task, and working memory-related activation of dorsolateral prefrontal cortex (DLPFC), and change in functional connectivity in brain network activity. This is the first randomized trial of response to TCC that integrates the use of fMRI biomarkers of response to guide the development of treatment and preventive approaches in geriatric depression.

Interventions

BEHAVIORALTai-Chi-Chih (TCC)
BEHAVIORALHealth Education and Wellness Classes (HEW)

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* A 24-item Hamilton Rating Scale for Depression (HAMD) score greater than 14 consistent with moderate-severe depression. * Mini-Mental State Exam (MMSE) score greater than 24. * Sufficient English proficiency and 8th grade or higher reading level as determined by the word reading subtest of the Wide Range Achievement Test-IV. * Capacity to provide informed consent. * A stable form of treatment for at least 4 months.

Exclusion criteria

* Any current or past psychiatric disorders, or recent unstable medical or neurological disorders * Any disabilities preventing their participation in Tai-Chi Chih exercise (e.g. severe visual or hearing impairment) * Insufficient English proficiency * Diagnosis of dementia * Mini Mental Health Examination score of 24 and below * Effective antidepressant, psychotropic medications, or effective therapy * Participation in a psychotherapy that involves cognitive training * Do not meet criteria for moderate-severe depression with a 24-item Hamilton Rating Scale for Depression (HAMD) score less than 14

Design outcomes

Primary

MeasureTime frameDescription
Change in Hamilton Depression Rating Scale (HDRS) ScoresMeasured at baseline and 3 monthsClinician administered scale measures severity of depressive symptoms. This measure includes 24 items. Response options vary item to item and include the following ranges: \[0-2\], \[0-3\], and \[0-4\]. A score of 0 suggests absence of symptoms and/or difficulties and higher scores represent more severe difficulties. Possible overall score range \[0-74\], higher scores representing more severe difficulties.

Secondary

MeasureTime frameDescription
Change in Delayed Recall Cognitive Domain ScoresMeasured at baseline and 3 monthsNeuropsychological battery of tests which included the following domains: Delayed Recall (CVLT-II \[Long-Delay Free Recall\], Rey-Osterrieth Complex Figure Test \[30-minute Delayed Recall\]) Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.
Change in Attention/Executive Function Cognitive Domain ScoresMeasured at baseline and 3 monthsNeuropsychological battery of tests which included the following domains: Attention/Executive Function (Trail Making Test A and B, Stroop Interference \[Golden version\]) Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.
Change in Language Cognitive Domain ScoresMeasured at baseline and 3 monthsNeuropsychological battery of tests which included the following domains: Language (Controlled Oral Word Association test \[FAS\], Animal Fluency, and Boston Naming Test) Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.

Other

MeasureTime frameDescription
Number of Participants With Adverse EventsMeasured at 3 monthsThe UKU (Udvalg for Kliniske Undersogelser) Side Effect Rating Scale organizes symptoms into 4 categories (i.e., Psychic, Neurologic, Autonomic, Other) containing 8-19 symptoms each. Each symptom receives a score for degree and causal relationship. Degree is scored between 0-3 with higher scores being more severe. Causal relationship is scored as improbable, possible, or probable.

Countries

United States

Participant flow

Pre-assignment details

220 participants were enrolled after providing consent and completing the screen visit. 178 participants completed baseline procedures and were randomized to either group.

Participants by arm

ArmCount
Tai-Chi Chih Classes
Participants will engage in 12 weekly 60 minute Tai-Chi-Chih classes. Tai-Chi-Chih (TCC)
89
Health Education and Wellness Classes
Participants will engage in 12 weekly 60 minute Health Education and Wellness classes. Health Education and Wellness Classes (HEW)
89
Total178

Baseline characteristics

CharacteristicHealth Education and Wellness ClassesTotalTai-Chi Chih Classes
Age, Continuous69.4 years
STANDARD_DEVIATION 6.2
69.3 years
STANDARD_DEVIATION 6.6
69.2 years
STANDARD_DEVIATION 6.9
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants6 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
85 Participants168 Participants83 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants4 Participants3 Participants
Hamilton Depression Rating Scale19.3 units on a scale
STANDARD_DEVIATION 3.9
19.15 units on a scale
STANDARD_DEVIATION 3.91
19.0 units on a scale
STANDARD_DEVIATION 4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants8 Participants5 Participants
Race (NIH/OMB)
Black or African American
8 Participants13 Participants5 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants4 Participants3 Participants
Race (NIH/OMB)
White
77 Participants153 Participants76 Participants
Region of Enrollment
United States
89 participants178 participants89 participants
Sex: Female, Male
Female
67 Participants129 Participants62 Participants
Sex: Female, Male
Male
22 Participants49 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 890 / 89
other
Total, other adverse events
4 / 893 / 89
serious
Total, serious adverse events
0 / 890 / 89

Outcome results

Primary

Change in Hamilton Depression Rating Scale (HDRS) Scores

Clinician administered scale measures severity of depressive symptoms. This measure includes 24 items. Response options vary item to item and include the following ranges: \[0-2\], \[0-3\], and \[0-4\]. A score of 0 suggests absence of symptoms and/or difficulties and higher scores represent more severe difficulties. Possible overall score range \[0-74\], higher scores representing more severe difficulties.

Time frame: Measured at baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Tai-Chi Chih ClassesChange in Hamilton Depression Rating Scale (HDRS) Scores-9.27 units on a scaleStandard Deviation 5.29
Health Education and Wellness ClassesChange in Hamilton Depression Rating Scale (HDRS) Scores-9.40 units on a scaleStandard Deviation 5.35
p-value: 0.3Mixed Models Analysis
Secondary

Change in Attention/Executive Function Cognitive Domain Scores

Neuropsychological battery of tests which included the following domains: Attention/Executive Function (Trail Making Test A and B, Stroop Interference \[Golden version\]) Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.

Time frame: Measured at baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Tai-Chi Chih ClassesChange in Attention/Executive Function Cognitive Domain Scores-0.04 z-scoreStandard Deviation 0.61
Health Education and Wellness ClassesChange in Attention/Executive Function Cognitive Domain Scores0.03 z-scoreStandard Deviation 0.53
p-value: 0.5Mixed Models Analysis
Secondary

Change in Delayed Recall Cognitive Domain Scores

Neuropsychological battery of tests which included the following domains: Delayed Recall (CVLT-II \[Long-Delay Free Recall\], Rey-Osterrieth Complex Figure Test \[30-minute Delayed Recall\]) Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.

Time frame: Measured at baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Tai-Chi Chih ClassesChange in Delayed Recall Cognitive Domain Scores-0.15 z-scoreStandard Deviation 0.57
Health Education and Wellness ClassesChange in Delayed Recall Cognitive Domain Scores-0.002 z-scoreStandard Deviation 0.61
p-value: 0.2Mixed Models Analysis
Secondary

Change in Language Cognitive Domain Scores

Neuropsychological battery of tests which included the following domains: Language (Controlled Oral Word Association test \[FAS\], Animal Fluency, and Boston Naming Test) Raw scores were transformed to z-scores (with a mean of 0 and standard deviation of 1) for each test score of interest across all participants. Thus the sample mean (across both arms) is zero for each test score. These z-scores were then averaged within each neuropsychological domain to produce composite scores. Higher scores are indicative of better performance.

Time frame: Measured at baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
Tai-Chi Chih ClassesChange in Language Cognitive Domain Scores0.03 z-scoreStandard Deviation 0.4
Health Education and Wellness ClassesChange in Language Cognitive Domain Scores-0.12 z-scoreStandard Deviation 0.46
p-value: 0.09Mixed Models Analysis
Other Pre-specified

Number of Participants With Adverse Events

The UKU (Udvalg for Kliniske Undersogelser) Side Effect Rating Scale organizes symptoms into 4 categories (i.e., Psychic, Neurologic, Autonomic, Other) containing 8-19 symptoms each. Each symptom receives a score for degree and causal relationship. Degree is scored between 0-3 with higher scores being more severe. Causal relationship is scored as improbable, possible, or probable.

Time frame: Measured at 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Tai-Chi Chih ClassesNumber of Participants With Adverse Events4 Participants
Health Education and Wellness ClassesNumber of Participants With Adverse Events3 Participants

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026